Logo image of INV

INNVENTURE INC (INV) Stock Fundamental Analysis

NASDAQ:INV - Nasdaq - US45784M1080 - Common Stock - Currency: USD

9.18  -1.57 (-14.6%)

Fundamental Rating

1

INV gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 225 industry peers in the Capital Markets industry. INV may be in some trouble as it scores bad on both profitability and health. INV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

INV had negative earnings in the past year.
INV had a negative operating cash flow in the past year.
INV Yearly Net Income VS EBIT VS OCF VS FCFINV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

The Return On Assets of INV (-5.67%) is worse than 85.39% of its industry peers.
INV's Return On Equity of -6.67% is on the low side compared to the rest of the industry. INV is outperformed by 83.11% of its industry peers.
Industry RankSector Rank
ROA -5.67%
ROE -6.67%
ROIC N/A
ROA(3y)4.03%
ROA(5y)N/A
ROE(3y)4.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
INV Yearly ROA, ROE, ROICINV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 4 -4

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for INV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INV Yearly Profit, Operating, Gross MarginsINV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

3

2. Health

2.1 Basic Checks

The number of shares outstanding for INV has been reduced compared to 1 year ago.
Compared to 1 year ago, INV has a worse debt to assets ratio.
INV Yearly Shares OutstandingINV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 5M 10M 15M 20M 25M
INV Yearly Total Debt VS Total AssetsINV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

INV has an Altman-Z score of 20.45. This indicates that INV is financially healthy and has little risk of bankruptcy at the moment.
INV has a Altman-Z score of 20.45. This is amongst the best in the industry. INV outperforms 97.26% of its industry peers.
INV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
INV's Debt to Equity ratio of 0.04 is amongst the best of the industry. INV outperforms 83.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 20.45
ROIC/WACCN/A
WACCN/A
INV Yearly LT Debt VS Equity VS FCFINV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

INV has a Current Ratio of 0.05. This is a bad value and indicates that INV is not financially healthy enough and could expect problems in meeting its short term obligations.
INV has a Current ratio of 0.05. This is amonst the worse of the industry: INV underperforms 94.98% of its industry peers.
INV has a Quick Ratio of 0.05. This is a bad value and indicates that INV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.05, INV is not doing good in the industry: 94.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
INV Yearly Current Assets VS Current LiabilitesINV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2M 4M 6M

0

3. Growth

3.1 Past

The earnings per share for INV have decreased strongly by -229.58% in the last year.
EPS 1Y (TTM)-229.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

INV is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -67.21% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-126.3%
EPS Next 3Y-67.21%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
INV Yearly Revenue VS EstimatesINV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2025 2026 20M 40M 60M 80M 100M
INV Yearly EPS VS EstimatesINV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2025 2026 -0.1 -0.2 -0.3 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

INV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INV Price Earnings VS Forward Price EarningsINV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INV Per share dataINV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

INV's earnings are expected to decrease with -67.21% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-126.3%
EPS Next 3Y-67.21%

0

5. Dividend

5.1 Amount

No dividends for INV!.
Industry RankSector Rank
Dividend Yield N/A

INNVENTURE INC

NASDAQ:INV (2/21/2025, 8:00:01 PM)

9.18

-1.57 (-14.6%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2024-11-14
Earnings (Next)N/A N/A
Inst Owners5.62%
Inst Owner ChangeN/A
Ins Owners26.35%
Ins Owner Change9.28%
Market Cap454.87M
AnalystsN/A
Price Target16.32 (77.78%)
Short Float %1.94%
Short Ratio4.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.24
P/tB 5.24
EV/EBITDA N/A
EPS(TTM)-0.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS1.75
TBVpS1.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.67%
ROE -6.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)4.03%
ROA(5y)N/A
ROE(3y)4.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z 20.45
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-229.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-342.41%
EPS Next YN/A
EPS Next 2Y-126.3%
EPS Next 3Y-67.21%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-456.74%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y40.25%
OCF growth 3YN/A
OCF growth 5YN/A